HOT NEWS
Bayer HealthCare joins forces with Stroke Alliance for Europe » Ahead of the "Move for Health Day" (10 May) and the "European Stroke Day" (14 May), the Stroke Allia...
Sanofi strengthens its French-German partnership » Sanofi (EURONEXT: SAN and NYSE: SNY) announced its involvement in two major Franco-German projects ...
Merck Serono to finance the launch of the EspeRare Foundation » Merck Serono, a division of Merck, Darmstadt, Germany, today announced the launch of the EspeRare Fo...
Bayer HealthCare to broaden strategic alliance with German Cancer Research Cente... » Bayer HealthCare (Bayer) and the German Cancer Research Center (DKFZ) will extend their successful s...
AstraZeneca and Karolinska Institutet to create Integrated Translational Researc... » AstraZeneca and the Swedish medical university Karolinska Institutet announced today their intention...
Innovative cervical screening app launches in UK and Ireland » The new Roche cobas® HPV Test app for iPad, which provides essential information about cervical can...
Roche obtains EU approval for PERJETA, a new personalised treatment for aggressi... » Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) has appr...
Novartis receives EU approval for Ilaris® in patients suffering acute gouty art... » Novartis announced that the European Commission (EC) has approved llaris (canakinumab, ACZ885) in th...
Genzyme Receives Company Award from European Organisation for Rare Diseases (EUR... » Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), ahas received a Company Award from EURORDIS...
Bayer supports innovative drug discovery in Europe » Bayer HealthCare initiated and will coordinate a newly founded pan-European consortium, named Europe...
GlaxoSmithKline
GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel
Title Filter     Display # 
# Article Title Hits
1 GSK and Theravance announce regulatory submission for ANORO™ (UMEC/VI) 3270
2 GSK announces submission for a new indication for Synflorix™ 2978
3 European Commission grants marketing authorisation for pazopanib (Votrient®) in the treatment of certain advanced soft tissue sarcoma subtypes 3243
4 GSK statement on BBC Panorama: "The truth about Sports Products" 3395
5 GSK statement on BBC Panorama broadcast: 'the truth about tax' 3721
6 GSK reinforces commitment to youth training 5057
7 MyAsthma App - a New Dimension in Asthma Control 5625
8 GlaxoSmithKline welcomes innovative knowledge-sharing collaboration 5900
9 Data published in The Lancet Oncology support high efficacy previously demonstrated by Cervarix® 4688
10 GSK delivers strong Q3 performance with underlying sales growth 5078
11 GlaxoSmithKline (GSK) and McLaren Group announce innovative strategic partnership 6248
12 GSK and Enigma Diagnostics announce collaboration 5882
13 GlaxoSmithKline European regulatory update on Pandemrix™ 5953
14 GlaxoSmithKline and Human Genome Sciences receive European authorisation for Benlysta® 5772
15 GlaxoSmithKline and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab) 6440
16 Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research 6009
17 Unique Research Alliance Expands Collaboration Opportunities 6182
18 GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction 6496
19 GSK outlines new plan to drive recruitment and attract graduate talent in the UK 6253
20 GSK's full year trading update 6408
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  Next 
  •  End 
  • »
Page 1 of 4